Mulligan BioCapital
Europe, Hamburg, Germany, Hamburg
Description
Mulligan BioCapital is an investment firm dedicated to the life sciences with a specific focus on biotechnology with health care
Investor Profile
Mulligan BioCapital has backed more than 6 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series A, Series Unknown rounds (top funding stages).
- Majority of deals are located in Germany, Switzerland.
- Strong thematic focus on Biotechnology, Medical, Biopharma.
Stage Focus
- Series C (33%)
- Series A (33%)
- Series Unknown (17%)
- Seed (17%)
Country Focus
- Germany (83%)
- Switzerland (17%)
Industry Focus
- Biotechnology
- Medical
- Biopharma
- Therapeutics
- Biomass Energy
- Industrial
- Health Care
- Genetics
- Pharmaceutical
- Oncology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
